Search

University of Witwatersrand, South Africa, University of Cape Town, and National Institute of Allergy and Infectious Diseases (NIAID)

UK Medical Research Council (MRC), European and Developing Countries Clinical Trials Partnership (EDCTP), Research Center Borstel, Imperial College London, University of Stellenbosch, National Taiwan University, Namibian National Tuberculosis and Leprosy Programme (NTLP), UK Foreign, Commonwealth & Development Office (FCDO), and Mareli Claassens, Associate research professor

Beijing Chest Hospital and Wen-hong Zhang, Head of Infectious Disease Department

University of Stellenbosch, National Health Laboratory Service (NHLS), South Africa, National Institute for Communicable Diseases, South Africa, National Institute of Allergy and Infectious Diseases (NIAID), Find, Translational Genomics Research Institute, and University Hospital Heidelberg

Johns Hopkins University

University of Cape Town, St George's, University of London, Emory University, and National Department of Health, South Africa

Regents of the University of California, University of Cape Town, Perinatal HIV Research Unit of the University of the Witswatersrand, and Francesca Conradie, Deputy Director

Centre for the AIDS Programme of Research in South Africa, National Institute of Allergy and Infectious Diseases (NIAID), and Max O'Donnell, MD,MPH,Principal investigator

Partners in Health, Harvard Medical School (HMS and HSDM), Epicentre, Institute of Tropical Medicine, Belgium, Socios En Salud, Peru, and Interactive Research and Development

Partners in Health, Harvard Medical School (HMS and HSDM), Epicentre, Institute of Tropical Medicine, Belgium, Socios En Salud, Peru, Interactive Research and Development, and University of San Francisco

Public Health Clinical Medical Center of Chengdu, Wuhan Institute for Tuberculosis Control, Changsha Central Hospital, Anhui Chest Hospital, Hunan Chest Hospital, and Shandong Public Health Clinical Center

National Institute of Allergy and Infectious Diseases (NIAID), Partners in Health, Socios En Salud Sucursal, Peru, and Molly Franke, Associate Professor of Global Health and Social Medicine

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and Otsuka Pharmaceutical Development & Commercialization, Inc.

Otsuka Pharmaceutical Development & Commercialization, Inc.

National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), and Medical Research Council, South Africa

University of Sussex, London School of Hygiene and Tropical Medicine, THINK TB & HIV Investigative Network, Wits Health Consortium (Pty) Ltd, Ministry of Public Health, Republic of Belarus, and Ministry of Health, Republic of Uzbekistan

London School of Hygiene and Tropical Medicine, Global Alliance for TB Drug Development, University College, London, Drugs for Neglected Diseases, Swiss Tropical & Public Health Institute, eResearch Technology, Inc., Ministry of Health, Republic of Uzbekistan, World Health Organization, Ministry of Public Health, Republic of Belarus, THINK TB & HIV Investigative Network, University of Liverpool, Wits Health Consortium (Pty) Ltd, Rutgers, The State University of New Jersey, and University of California, San Francisco

London School of Hygiene and Tropical Medicine, Ministry of Health, Republic of Uzbekistan, Ministry of Public Health, Republic of Belarus, THINK TB & HIV Investigative Network, University of Liverpool, and Wits Health Consortium (Pty) Ltd

Novartis Pharmaceuticals, Pfizer, Otsuka Pharmaceutical Co., Ltd., University of California, San Francisco, Westat, National Institute of Allergy and Infectious Diseases (NIAID), University of Colorado, Denver, Harvard Medical School (HMS and HSDM), National Lung Hospital, Vietnam, De La Salle Health Sciences Institute, Philippines, and Charles R Horsburgh, Professor of Epidemiology, Boston University

Christoph Lange, Head of International Health / Infectious Diseases, University Lübeck

'Marius Nasta' Pulmonology Institute, Ludwig-Maximilians - University of Munich, and Christoph Lange, Chief investigator

National Center for Tuberculosis and Lung Disease, Tbilisi, Georgia and Perinatal HIV Research Unit of the University of the Witswatersrand

National Center for Tuberculosis and Lung Disease, Tbilisi, Georgia and Cris Vilaplana, Senior Researcher at the Experimental Tuberculosis Unit

KNCV Tuberculosis Foundation, Amsterdam Institute for Global Health and Development, Ospedale San Raffaele, Foundation for Innovative New Diagnostics, Switzerland, National Institute for Medical Research, Tanzania, University of St Andrews, Global Alliance for TB Drug Development, Wits Health Consortium (Pty) Ltd, Institute of Human Virology, Nigeria, Ethiopian Public Health Institute, and Dr Kogieleum Naidoo, Associate Professor

Damien Foundation

West China Hospital, Wuhan Pulmonary Hospital (Wuhan Institute For Tuberculosis Control), and Chu naihui, TB Director

Ludwig-Maximilians - University of Munich

V. N. Karazin Kharkiv National University, Kenya Medical Research Institute, Universidad Peruana Cayetano Heredia, and Bioneer Corporation

Medical Research Council, Institute of Tropical Medicine, Belgium, Liverpool School of Tropical Medicine, and Rede TB

Dr Nesri Padayatchi, Deputy Director

University of Stellenbosch, Ospedale San Raffaele, Stichting Katholieke Universiteit, University of Cape Town Lung Institute, and Keertan Dheda, Professor

National Institute of Allergy and Infectious Diseases (NIAID), Centers for Disease Control and Prevention, Macleods Pharmaceuticals Ltd, and Charles R Horsburgh, Professor, Epidemiology

Wen-hong Zhang, Director of Division of Infectious Diseases

Wen-hong Zhang, Director of Division of Infectious Diseases

Institute of Tropical Medicine and World Health Organization

Wen-hong Zhang, Director of Division of Infectious Diseases

Rwanda Biomedical Centre, The Tuberculosis Reference Laboratory Bamenda, Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo, Jimma University, Service de Pneumophtisiologie, Hôpital Ignace Deen, University of the Sciences, Techniques and Technologies of Bamako, Damien Foundation, Cheikh Anta Diop University, Senegal, Institute of Tropical Medicine, Belgium, World Health Organization, London School of Hygiene and Tropical Medicine, Genoscreen, and Dissou AFFOLABI, Professor (Deputy Head of the Laboratory)